Literature DB >> 23809334

Management of challenging cases of patients with cancer-associated thrombosis including recurrent thrombosis and bleeding: guidance from the SSC of the ISTH.

M Carrier, A A Khorana, J I Zwicker, S Noble, A Y Y Lee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23809334     DOI： 10.1111/jth.12338

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  34 in total

1.  Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 1: prophylaxis.

Authors:  J C Easaw; M A Shea-Budgell; C M J Wu; P M Czaykowski; J Kassis; B Kuehl; H J Lim; M MacNeil; D Martinusen; P A McFarlane; E Meek; O Moodley; S Shivakumar; V Tagalakis; S Welch; P Kavan
Journal:  Curr Oncol       Date:  2015-04       Impact factor: 3.677

2.  PICC-related upper deep venous thrombosis in patients with hematological malignancies. Management of anticoagulant therapy according to the platelet count.

Authors:  Maria Cristina Scamuffa; Salvatore Giacomo Morano; Alessandra Serrao; Antonella Bruzzese; Francesca Stocchi; Cristina Santoro; Federico Vozella; Roberto Latagliata; Antonio Chistolini
Journal:  J Thromb Thrombolysis       Date:  2020-04       Impact factor: 2.300

3.  Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice.

Authors:  J E Geddings; Y Hisada; Y Boulaftali; T M Getz; M Whelihan; R Fuentes; R Dee; B C Cooley; N S Key; A S Wolberg; W Bergmeier; N Mackman
Journal:  J Thromb Haemost       Date:  2015-12-11       Impact factor: 5.824

Review 4.  Anticoagulation in Cancer Patients: a Summary of Pitfalls to Avoid.

Authors:  Harsh K Patel; Alok A Khorana
Journal:  Curr Oncol Rep       Date:  2019-02-04       Impact factor: 5.075

5.  Venous thromboembolism in cancer patients: a call for more awareness.

Authors:  A Delluc; M Carrier
Journal:  Curr Oncol       Date:  2014-08       Impact factor: 3.677

Review 6.  Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy.

Authors:  Hanny Al-Samkari; Jean M Connors
Journal:  Blood Adv       Date:  2019-11-26

7.  Clinical challenges in patients with cancer-associated thrombosis: Canadian expert consensus recommendations.

Authors:  M Carrier; A Lazo-Langner; S Shivakumar; V Tagalakis; P L Gross; N Blais; C A Butts; M Crowther
Journal:  Curr Oncol       Date:  2015-02       Impact factor: 3.677

8.  Inferior vena cava filters: use or abuse?

Authors:  Davide Imberti; Daniela Mastroiacovo
Journal:  Intern Emerg Med       Date:  2017-12-29       Impact factor: 3.397

Review 9.  Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus.

Authors:  Mariasanta Napolitano; Giorgia Saccullo; Marco Marietta; Monica Carpenedo; Giancarlo Castaman; Elisabetta Cerchiara; Antonio Chistolini; Laura Contino; Valerio De Stefano; Anna Falanga; Augusto B Federici; Elena Rossi; Rita Santoro; Sergio Siragusa; Valerio De Stefano; Anna Falanga; Alberto Tosetto; Giuseppe Avvisati; Monica Carpenedo; Augusto B Federici; Marco Marietta; Mariasanta Napolitano; Elena Rossi; Cristina Santoro; Giancarlo Castaman; Elisabetta Cerchiara; Antonio Chistolini; Laura Contino; Maria Gabriella Mazzucconi; Ilaria Nichele; Laura Russo; Roberto Santi; Rita Carlotta Santoro; Sergio Siragusa; Giuseppe Tagariello
Journal:  Blood Transfus       Date:  2018-10-24       Impact factor: 3.443

10.  Management of venous thromboembolism during thrombocytopenia after autologous hematopoietic cell transplantation.

Authors:  Ang Li; Chris Davis; Qian Wu; Shan Li; Madeline F Kesten; Leona A Holmberg; Ajay K Gopal; David A Garcia
Journal:  Blood Adv       Date:  2017-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.